There is no link between vitamin D levels in infancy to adult-onset multiple sclerosis, according to research conducted by the Karolinska Institutet in Sweden.
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials.
The big question is whether it will work, researchers said.
Treatment-naive patients with multiple myeloma frequently have sensory deficits, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Cerebrospinal fluid biomarkers for Alzheimer's disease, particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype, according to a study published online Aug. 27 in JAMA Psychiatry.
For patients with Parkinson's disease undergoing deep brain stimulation (DBS), increasing age does not impact complication rates, according to a study published online Aug. 25 in JAMA Neurology.
Looking back over a 30-year career in pain medicine, the author laments the shift from comprehensive, multidisciplinary pain care to a model that focuses on pills and procedures to treat chronic pain.